A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)
Clinical trial NCT03369236 · COMPLETED
Trial details
- NCT number
- NCT03369236
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2019-12-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.